Congratulations to Inteligex CMO and CEO, Dr. Chris Ahuja, on being recognized with the Golden Scalpel Award from the Canadian Association of Chairs of Surgical Research!!!

http://cacsr.ca/golden-scalpel-award/

Check out Inteligex's website to learn more about the exciting work being done in Toronto!! #spinalcordinjury #SCI #stemcells #regeneration #innovation #Toronto

https://www.inteligex.ca/

Inteligex President and Founder Dr. Michael Fehlings will be giving an update on Cervical Myelopathy at the World Spinal Column Society tomorrow! #innovation #spine #health

There are distinct neuronal subtypes in the #brain and #spinal_cord. Our #SMaRTcells and #InteliCells have the potential to differentiate into exact neuronal subtypes in the spinal cord and restore the interrupted circuits.

Cell transplantation for #SCI should be patient specific. Various injury characteristics such as cause, level, severity, and age divide individuals with SCI into many subgroups. In our #precision_medicine approach, we have developed different cell types for different patients.

Inteligex uses a personalized medicine approach to process patient data using proprietary AI technology and chooses the best regenerative cell type (InteliCells, SMaRT Cells or WiseCells) to match each individual's condition. @DrFehlings #SCI #spine #stemcells #repair #health

Overview of IPS cell prospects for clinical impact including trials such as for cancer, drug screening, and disease modeling. I updated the post by my intern to include more trials
https://ipscell.com/2020/10/overview-of-ips-cell-prospects-for-clinical-impact/ #stemcells #stemcell

On Friday, Inteligex President and Founder Dr. Michael Fehlings gave a presentation for the Tator-Turnbull Symposium. A highlight from his talk is below discussing some of our exciting technologies! #stemcells #regeneration #spinalcordinjury #SCI #hope

load more...